Can you please provide us with a brief summary of what you plan to cover in today’s CME program focusing on new advances in CD/LD-based treatment of PD, including the scored, fractionable dosing formulation of CD/LD?
Can you please provide us with a brief summary of what you plan to cover in today’s CME program focusing on new advances in CD/LD-based treatment of PD, including the scored, fractionable dosing formulation of CD/LD?
Created by
Related Presenters
Associate Professor, Department of Neurology Georgetown University Medical Center Vice Chair of Finance Director, Residency Program Director, Botulinum Toxin Clinic Associate Professor of Neurology Medstar Georgetown University HospitalWashington, D.C.